Month completed: July 2007

Dia-B Tech is a company I have been watching for a while. They are currently in the early stages of developing drugs that will aid the treatment of Type 1 and 2 diabetes.

Given the increasing levels of obesity around the world (as well as other factors), the number of people worldwide who suffer from diabetes is predicted to increase by 55% by 2025 (from 246 to 380 million). Although I am not a diabetes sufferer myself, I can see the importance of investing in companies that are working on ways to make life for those with diabetes a little bit better.

Dia-B Tech’s mission statement is as follows:

Dia-B’s underlying strategy and objective is the discovery and development of pharmaceuticals, diagnostics and treatments for diabetes and diabetes-related diseases.

Their main work at present focuses on a drug that lowers blood glucose levels as well as increasing the body’s sensitivity to insulin, meaning the insulin the diabetic needs is able to work harder. You can find out more at their website.

I have bought 15,000 shares. I don’t expect to see much of a return until maybe 2010, and given this is just a speculative purchase, I may lose all my money. But that’s the fun of the stockmarket, isn’t it!